Predictive Oncology: Funding, Investors & Team (Oct 2026)
Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies.
Predictive Oncology has raised $21.3M across 1 funding round on record, the most recent an undisclosed round of $21.3M announced in Jun 2021.
That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Predictive Oncology Company Profile and Key Stats
Latest funding round on record: Jun 2021.
Predictive Oncology Funding Rounds
Predictive Oncology Founders and Leadership Team
No contact details are on record for this team yet.
Predictive Oncology Funding Compared to Other Health Care Startups
Predictive Oncology's latest round of $21.3M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Predictive Oncology in Health Care and Eagan
Companies Similar to Predictive Oncology
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Predictive Oncology Funding FAQs
What does Predictive Oncology do?
Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies.
How much funding has Predictive Oncology raised?
Predictive Oncology has raised $21.3M across 1 round on record. The most recent is an undisclosed round of $21.3M announced in Jun 2021.
When did Predictive Oncology last raise funding?
Predictive Oncology's most recent funding round on record is an undisclosed round of $21.3M, announced in Jun 2021.
Who is the CEO of Predictive Oncology?
Melville Engle is listed as CEO at Predictive Oncology.
Where is Predictive Oncology headquartered?
Predictive Oncology is based in Eagan, Minnesota, United States.
How many employees does Predictive Oncology have?
Predictive Oncology is in the 11-50 employee band.
How does Predictive Oncology's funding compare to other Health Care startups?
Predictive Oncology's latest round of $21.3M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Predictive Oncology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Predictive Oncology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.